Mark Waer | Academic Influence

Mark Waer's AcademicInfluence.com Rankings

Mark Waer

Philosophy

#10523

World Rank

#14428

Historical Rank

Logic

#7394

World Rank

#9138

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Mark Waer's Degrees

Doctorate Medicine KU Leuven
PhD Biomedical Sciences KU Leuven

Why Is Mark Waer Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Mark Jozef Albert, Baron Waer is a Belgian physician, biomedical scientist, and former Rector of the Katholieke Universiteit Leuven. Biography From 1969 to 1976, Waer studied medicine at the Katholieke Universiteit Leuven in Leuven. In 1981, he was qualified the Specialist of Internal Medicine in nephrology. In 1983, he obtained PhD in medical sciences.

(See a Problem?)

Mark Waer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. (1999) (624)
Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3 (1994) (408)
Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. (1991) (403)
1,25-Dihydroxyvitamin D3 Prevents Insulitis in NOD Mice (1992) (243)
The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. (1992) (228)
1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). (2000) (174)
Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. (1995) (166)
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. (2008) (157)
Comparative In Vitro Immune Stimulation Analysis of Primary Human B Cells and B Cell Lines (2016) (146)
Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. (1997) (139)
The Vitamin D Analog, TX527, Promotes a Human CD4+CD25highCD127low Regulatory T Cell Profile and Induces a Migratory Signature Specific for Homing to Sites of Inflammation (2011) (132)
Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. (1998) (121)
Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants. (2000) (114)
Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. (1998) (106)
Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 α, 25-(OH)2D3 (1995) (99)
Immunosuppressive Activity of Peritoneal Fluid in Women With Endometriosis (1993) (91)
Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis (1990) (90)
HAEMODIALYSIS MEMBRANES, SERUM β2-MICROGLOBULIN, AND DIALYSIS AMYLOIDOSIS (1986) (88)
G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. (2012) (87)
Immunomodulatory effects of 1,25‐dihydroxyvitamin D3 (1995) (86)
1,25‐Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo (2011) (83)
Inhibitory and Stimulatory Effects of Cyclosporine A on the Development of Regulatory T Cells In Vivo (2005) (82)
Induction of specific transplantation tolerance across xenogeneic barriers in the T-independent immune compartment (1998) (82)
Unaltered Diabetes Presentation in NOD Mice Lacking the Vitamin D Receptor (2008) (78)
Human Multipotent Adult Progenitor Cells Are Nonimmunogenic and Exert Potent Immunomodulatory Effects on Alloreactive T-Cell Responses (2013) (75)
Immune Regulation of 25-Hydroxyvitamin D-1α-Hydroxylase in Human Monocytic THP1 Cells: Mechanisms of Interferon-γ-Mediated Induction (2006) (71)
Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions. (2003) (69)
Inflammatory Gene Expression Profile and Defective Interferon‐γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients (2017) (68)
Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants. (2002) (60)
Changes of lymphocyte subsets after local irradiation for early stage breast cancer and seminoma testis: long-term increase of activated (HLA-DR+) T cells and decrease of "naive" (CD4-CD45R) T lymphocytes. (1992) (60)
Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts. (1998) (59)
Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts. (2000) (58)
Xenotransplantation: where are we in 2008? (2008) (56)
Flow Cytometry Analysis of Lymphocyte Subpopulations in Peritoneal Fluid of Women With Endometriosis (1994) (55)
Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D (2009) (55)
Contribution of activated macrophages to the process of delayed xenograft rejection. (1997) (54)
RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection (2015) (49)
Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect. (2007) (47)
CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease (2007) (47)
Treatment of autoimmune diabetes recurrence in non‐obese diabetic mice by mouse interferon‐β in combination with an analogue of 1α,25‐dihydroxyvitamin‐D3 (2002) (47)
Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved. (1997) (46)
Xenotransplantation: role of natural immunity. (2009) (46)
Sex difference in resistance to dexamethasone-induced apoptosis in NOD mice: treatment with 1,25(OH)2D3 restores defect. (1998) (44)
TREATMENT OF CADAVERIC RENAL TRANSPLANT RECIPIENTS WITH TOTAL LYMPHOID IRRADIATION, ANTITHYMOCYTE GLOBULIN, AND LOW-DOSE PREDNISONE (1985) (44)
Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis (2016) (43)
Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents (2003) (43)
Regulatory Cells, Th1/Th2 Unbalance, and Antibody-Induced Chronic Rejection in Operational Tolerance Induced by Donor-Specific Blood Transfusion (2005) (43)
Regulatory cell-mediated tolerance does not protect against chronic rejection (2003) (43)
Experimental and clinical approaches for optimization of the graft-versus-leukemia effect (2007) (41)
Early Presence of Regulatory Cells in Transplanted Rats Rendered Tolerant by Donor-Specific Blood Transfusion1 (2005) (38)
Suppression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats. (1998) (37)
Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells. (2007) (36)
Isolated zygomycosis in a bought living unrelated kidney transplant (1996) (36)
Immune regulation of 25-hydroxyvitamin D-1alpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-gamma-mediated induction. (2006) (35)
Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: synergy with cyclosporine. (1994) (35)
Discovery of 7-N-piperazinylthiazolo[5,4-d]pyrimidine analogues as a novel class of immunosuppressive agents with in vivo biological activity. (2011) (34)
Effect of a presumed consent law on organ retrieval in Belgium. (1990) (34)
Natural killer cell- and macrophage mediated discordant guinea pig-->rat xenograft rejection in the absence of complement, xenoantibody and T cell immunity. (2000) (34)
Aminoacyl-tRNA synthetase inhibitors as potent and synergistic immunosuppressants. (2008) (32)
Immunohistochemical characterization of leucocyte subpopulations in endometriotic lesions (1993) (32)
Differentiation induction of human leukemia cells (HL60) by a combination of 1,25-dihydroxyvitamin D3 and retinoic acid (all trans or 9-cis) (1995) (32)
The Leuven Immunomodulatory Protocol Promotes T‐Regulatory Cells and Substantially Prolongs Survival After First Intestinal Transplantation (2016) (31)
9-(2-phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine: a novel prodrug of 9-(2-phosphonylmethoxyethyl)guanine with improved antitumor efficacy and selectivity in choriocarcinoma-bearing rats. (1999) (31)
Three years of experience with a presumed consent legislation in Belgium : its impact on multi-organ donation in comparison with other european countries (1991) (31)
Transforming growth factor-beta inhibits lymphokine activated killer cytotoxicity of bone marrow cells: implications for the graft-versus-leukemia effect in irradiation allogeneic bone marrow chimeras. (2001) (31)
Subset characterization of myeloid-derived suppressor cells arising during induction of BM chimerism in mice (2012) (30)
Potent antitumor activity of the acyclic nucleoside phosphonate 9‐(2‐phosphonylmethoxyethyl)adenine in choriocarcinoma‐bearing rats (1998) (30)
Influence of radiation field and fractionation schedule of total lymphoid irradiation (TLI) on the induction of suppressor cells and stable chimerism after bone marrow transplantation in mice. (1984) (29)
Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo- and xenotransplantation in rats. (1996) (29)
Allogeneic bone marrow transplantation in mice after total lymphoid irradiation: influence of breeding conditions and strain of recipient mice. (1984) (29)
Virus-specific MHC-restricted T lymphocytes may initiate allograft rejection. (1985) (28)
Three years of experience with a 'presumed consent' legislation in Belgium: its impact on multi-organ donation in comparison with other European countries. The Leuven Collaborative Group for Transplantation. (1991) (26)
Comparison of the immunosuppressive effect of fractionated total lymphoid irradiation (TLI) vs conventional immunosuppression (CI) in renal cadaveric allotransplantation. (1984) (25)
A combination of KH1060, a vitamin D(3) analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice. (2001) (25)
Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model. (1995) (24)
Potential role of 1,25(OH)2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506. (1994) (24)
Graft-versus-leukemia effect in minor antigen mismatched chimeras given delayed donor leucocyte infusion: immunoregulatory aspects and role of donor T and ASGM1-positive cells. (2000) (23)
Purulent meningitis due to aspergillosis in a patient with systemic lupus erythematosus (1992) (23)
Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression. (2002) (22)
Factors involved in rejection of concordant xenografts in complement-deficient rats. (1997) (22)
Transplantation Tolerance and Autoimmunity After Xenogeneic Thymus Transplantation1 (2001) (21)
Activated form of vitamin D [1,25(OH)2D3] and its analogs are dose-reducing agents for cyclosporine in vitro and in vivo. (1994) (21)
FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A (2003) (21)
Lymphokine-activated killer activity in women with endometriosis. (1994) (21)
Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine. (1994) (20)
IgA antiglomerular basement membrane disease associated with bronchial carcinoma and monoclonal gammopathy. (1999) (20)
Induction of transplantation tolerance in mice across major histocompatibility barrier by using allogeneic thymus transplantation and total lymphoid irradiation. (1990) (20)
Intestinal Ischemia Reperfusion and Lipopolysaccharide Transform a Tolerogenic Signal into a Sensitizing Signal and Trigger Rejection (2009) (20)
Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: Perspective on mechanisms of action (2008) (20)
Addition of steroids blocks the tolerogenic potential of donor-specific blood transfusion. (2001) (19)
Haemodialysis membranes, serum beta 2-microglobulin, and dialysis amyloidosis. (1986) (19)
Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D3 in combination with cyclosporin A. (1996) (19)
Effects of a Short Course of Leflunomide on T-Independent B-Lymphocyte Xenoreactivity and on Susceptibility of Xenografts to Acute or Chronic Rejection (2005) (19)
Synthesis and in vitro evaluation of 2-amino-4-N-piperazinyl-6-(3,4-dimethoxyphenyl)-pteridines as dual immunosuppressive and anti-inflammatory agents. (2011) (18)
Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo. (2018) (18)
Mouse MAPC-mediated immunomodulation: Cell-line dependent variation. (2010) (18)
Prevention of diabetes recurrence after syngeneic islet transplantation in NOD mice by analogues of 1,25(OH)2D3 in combination with cyclosporin A: mechanism of action involves an immune shift from Th1 to Th2. (1998) (18)
Prevention of type I diabetes in NOD mice by 1,25- dihydroxyvitamin D 3 and its analog (1994) (18)
The aging kidney donor: another answer to organ shortage? The Leuven Collaborative Group for Transplantation. (1990) (18)
[Immune modulation by vitamin D analogs in the prevention of autoimmune diseases]. (1995) (17)
CD4+ T Lymphocytes Expressing CD40 Ligand Help the IgM Antibody Response to Soluble Pneumococcal Polysaccharides via an Intermediate Cell Type1 (2006) (17)
Effect of leflunomide and cyclosporine on the occurrence of chronic xenograft lesions. (1995) (17)
Listeria monocytogenes meningitis (1989) (17)
Recipient lymphocyte infusion in MHC-matched bone marrow chimeras induces a limited lymphohematopoietic host-versus-graft reactivity but a significant antileukemic effect mediated by CD8+ T cells and natural killer cells (2011) (17)
CO2-laser excision of endometriosis does not improve the decreased natural killer activity. (1994) (16)
Synthesis, immunosuppressive activity and structure-activity relationship study of a new series of 4-N-piperazinyl-thieno[2,3-d]pyrimidine analogues. (2010) (16)
Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3. (2002) (16)
Paradoxical early upregulation of intragraft Th1 cytokines is associated with graft acceptance following donor-specific blood transfusion (2003) (16)
Graft-versus-host reactivity and graft-versus-leukemia effect in murine allogeneic bone marrow chimeras conditioned with total body irradiation or total lymphoid irradiation. (1996) (16)
Immunologic changes after loco-regional radiotherapy and fractionated total body irradiation (TBI) in mice. (1989) (15)
Corticosteroid withdrawal syndrome in dialysis patients. (1988) (15)
Blockade of induced xenoantigen expression prevents rejection after retransplantation of accommodated hamster-to-rat heart xenografts. (1998) (14)
Evaluation of anti‐human leukocyte antigen allo‐immunization in pediatric cadaveric kidney transplantation (2000) (14)
Pathogenesis of Autoimmunity After Xenogeneic Thymus Transplantation1 (2003) (14)
EVIDENCE THAT STIMULATOR CELL‐DERIVED IL‐6 AND IL‐1 ARE RELEASED IN THE MIXED LYMPHOCYTE CULTURE BUT ARE NOT REQUISITE FOR RESPONDER T CELL PROLIFERATION (1992) (14)
Peritransplant lymphocele causing arterial hypertension by a Page kidney phenomenon. Leuven Collaborative Group for Transplantation. (1997) (14)
IMMUNOLOGICAL AND CLINICAL OBSERVATIONS IN DIABETIC KIDNEY GRAFT RECIPIENTS PRETREATED WITH TOTAL‐LYMPHOID IRRADIATION (1987) (14)
Long-term prognosis after cadaveric kidney transplantation. (1987) (13)
Increased Mortality and Impaired Clonal Deletion After Staphylococcal Enterotoxin B Injection in Old Mice: Relation to Cytokines and Nitric Oxide Production (1997) (13)
Subclinical GvHD in non-irradiated F1 hybrids: severe lymphoid-tissue GvHD causing prolonged immune dysfunction (2011) (13)
Effect of leflunomide on T-independent xenoantibody formation in rats receiving hamster heart xenografts. (1996) (13)
CO2‐laser excision of endometriosis does not improve the decreased natural killer activity (1994) (13)
The relative impact of legislative incentives on multi-organ donation rates in Europe. (1995) (13)
Interferon therapy in multiple myeloma: failure of human fibroblast interferon administration to the course of light chain disease. (1981) (13)
Anaphylactoid reactions, haemodialysis, and ACE inhibitors (1991) (13)
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease? (2007) (12)
Induction of mixed bone marrow chimerism as potential therapy for autoimmune (type I) diabetes: experience in the NOD model. (1995) (12)
Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone. (1994) (12)
A prospective, randomized trial of pretransplant blood transfusions in cadaver kidney transplant candidates (1994) (12)
Primary sclerosing cholangitis associated with membranous nephropathy. (1988) (12)
Synthesis of a 2,4,6-trisubstituted 5-cyano-pyrimidine library and evaluation of its immunosuppressive activity in a Mixed Lymphocyte Reaction assay. (2013) (12)
Spontaneous reestablishment of self-tolerance in BB/Pfd rats. (1994) (12)
Measurement of alloantibody by flow cytometry. (1990) (12)
In vivo mechanism of action of leflunomide: selective inhibition of the capacity of B lymphocytes to make T-independent xenoantibodies. (1996) (12)
Islet xenograft destruction in the hu‐PBL‐severe combined immunodeficient (SCID) mouse necessitates anti‐CD3 preactivation of human immune cells (2000) (11)
Maintenance and reversibility of natural killer cell- and T cell-independent B lymphocyte xenotolerance in athymic nude rats. (1999) (11)
Early Accumulation of Interferon-&ggr; in Grafts Tolerized by Donor-Specific Blood Transfusion: Friend or Enemy? (2004) (11)
γ-Hydroxyethyl piperidine iminosugar and N-alkylated derivatives: a study of their activity as glycosidase inhibitors and as immunosuppressive agents. (2014) (11)
Effect of staphylococcal enterotoxin B injection on the development of experimental autoimmune encephalomyelitis: influence of cytokine and inducible nitric oxide synthase production (1999) (10)
Lack of disease recurrence in diabetic BB/Pfd rats after syngeneic islet transplantation. (1993) (10)
The graft‐versus‐neuroblastoma effect of allogeneic hematopoietic stem cell transplantation, a review of clinical and experimental evidence and a perspective on mechanisms (2014) (10)
Influence of overall treatment time in a fractionated total lymphoid irradiation as an immunosuppressive therapy in allogeneic bone marrow transplantation in mice. (1982) (10)
Oct4-negative multipotent adult progenitor cells and mesenchymal stem cells as regulators of T-cell alloreactivity in mice. (2011) (10)
Use of the methylxanthine derivative A802715 in transplantation immunology: I. Strong in vitro inhibitory effects on CD28-costimulated T cell activities. (1997) (10)
Break of tolerance via donor-specific blood transfusion by high doses of steroids: a differential effect after intestinal transplantation and heart transplantation. (2003) (10)
IL-7 Is Required for the Development of the Intrinsic Function of Marginal Zone B Cells and the Marginal Zone Microenvironment (2011) (10)
Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells. (1999) (9)
Mechanisms involved in long-term hamster-to-rat cardiac xenograft survival. (1996) (9)
CT demonstration of aneurysms in polyarteritis nodosa. (1986) (9)
The influence of donor age on initial and long‐term renal allograft outcome (1994) (9)
Leflunomide, malononitriloamides, and transplantation immunology* (1998) (9)
Shortage of kidneys, a solvable problem? The Leuven experience. Leuven Collaborative Group for Transplantation. (1988) (9)
Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras (2018) (9)
Treatment of murine lupus nephritis with cyclophosphamide or total lymphoid irradiation. (1988) (9)
The use of leflunomide in transplantation immunology. (1996) (8)
Recipient leukocyte infusion enhances the local and systemic graft-versus-neuroblastoma effect of allogeneic bone marrow transplantation in mice (2013) (8)
Tolerance induction with FTY720 and donor-specific blood transfusion: discrepancy between heart transplantation and intestinal transplantation. (2000) (8)
Renal cadaveric transplantation after total lymphoid irradiation in patients with diabetes. (1983) (8)
An easy and reproducible model of kidney transplantation in rats. (2009) (8)
The technical aspects of combined intestinal and heart transplantation in rats. (2001) (8)
Effect of Treatments with Cyclosporin A and Anti‐Interferon‐γ Antibodies on the Mechanisms of Immune Tolerance in Staphylococcal Enterotoxin B Primed Mice (1997) (8)
Interleukin-1 receptor antagonist inhibits primary non-function and prolongs graft survival time of xenogeneic islets transplanted in spontaneously diabetic autoimmune NOD mice (2002) (8)
A prospective, randomized trial of pretransplant blood transfusions in cadaver kidney transplant candidates. Leuven Collaborative Group for Transplantation. (1994) (8)
A subset of asialo GM1+ cells play a protective role in the occurrence of graft-versus-host disease in mice. (1991) (8)
Bilateral nephrectomy of the native kidneys reduces the incidence of arterial hypertension and erythrocytosis in kidney graft recipients treated with cyclosporin. Leuven Collaborative Group for Transplantation. (1992) (8)
Protection against autoimmune diabetes by induction of mixed bone marrow chimerism. (1993) (7)
Identification and function of a major OKT3, OKT8, Leu-7, positive lymphocyte subpopulation in renal transplant recipients treated with total lymphoid irradiation. (1987) (7)
Renal transplantation in diabetes after total lymphoid irradiation (TLI) (1983) (7)
The role of anti-DNA antibodies in lupus nephritis (1990) (7)
EFFECTS OF THYMUS IRRADIATION ON THE IMMUNE COMPETENCE OF T CELLS AFTER TOTAL‐LYMPHOID IRRADIATION (1990) (7)
Normal and malignant trophoblasts do not recruit granulated metrial gland cells. (1996) (7)
Natural killer cells, antibody-dependent cellular cytotoxicity, and complement synthesis by the xenograft itself play a role in xenograft rejection. (1995) (6)
Increased incidence of murine graft-versus-host disease after allogeneic bone marrow transplantation by previous infusion of syngeneic bone marrow cells. (1984) (6)
Late CD8+ T Cell-Dependent Xenoantibody Production in Innate Tolerant Nude Rats After Hamster Islet Grafting But Not After Hamster Heart Grafting (2008) (6)
Solid Tumor-Induced Immune Regulation Alters the GvHD/GvT Paradigm after Allogenic Bone Marrow Transplantation. (2019) (6)
Biopty device for obtaining kidney specimens. (1990) (6)
Blockade of CTLA‐4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides (2005) (6)
TOTAL LYMPHOID IRRADIATION IN RENAL CADAVERIC TRANSPLANTATION IN DIABETICS (1985) (5)
Facilitation of allogeneic bone marrow engraftment in mice by total lymphoid irradiation combined with total-body irradiation. (1983) (5)
Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes (2021) (5)
Kidney allograft tolerance in diabetic patients after total lymphoid irradiation (TLI). (1985) (5)
Duplex Doppler evaluation of renal allograft dysfunction. (1989) (5)
Induction and Maintenance of T-dependent or T-independent Xenotolerance by Nonprimarily-Vascularized Skin or Thymus Grafts (2005) (5)
Induction of T-independent xenotolerance in a semi-discordant hamster-to-presensitized, nude rat model. (1999) (5)
Induction of tolerance by donor-specific blood transfusion in a model of intestinal transplantation: technical and immunological aspects. (2002) (5)
Allogeneic bone marrow transplantation and donor lymphocyte infusion in a mouse model of irradiation-induced myelodysplastic/myeloproliferation syndrome (MD/MPS): evidence for a graft-versus-MD/MPS effect (2009) (5)
Role of CD4+ and CD8+ T cells in the rejection of heart or islet xenografts in recipients with xenotolerance in the innate immune compartment. (2005) (5)
Factors determining the success rate of total lymphoid irradiation in clinical kidney transplantation. (1989) (5)
Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile. (2010) (5)
Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats. (1996) (5)
Occurrence of autoimmunity after xenothymus transplantation in T-cell-deficient mice depends on the thymus transplant technique. (2008) (5)
Improved Anti-Tumour Adaptive Immunity Can Overcome the Melanoma Immunosuppressive Tumour Microenvironment (2019) (5)
Cadaveric kidney transplantation in diabetics after total lymphoid irradiation (TLI). (1984) (4)
In vitro and in vivo inhibitory activity of the differentiation-inducing agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against rat choriocarcinoma. (1998) (4)
Immunomodulatory effects of pretransplant donor blood transfusion on T-cell-independent xenoreactive immunity. (2000) (4)
A controlled trial of one month versus 3 months cyclosporine and conversion to azathioprine in renal-transplantation (1985) (4)
Role of growth arrest specific gene 6 in immune and non-immune aspects of vascular lesions occurring during delayed xenograft rejection (2005) (4)
A short-term combination therapy with cyclosporine and rapamycin or leflunomide induces long-term heart allograft survival in a strongly immunogenic strain combination in rats (1996) (4)
Renal cadaveric transplantation in diabetics using total lymphoid irradiation or cyclosporin A (1988) (4)
Rejection of cardiac xenografts by NK cells and macrophages. (1997) (4)
Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients. (1988) (4)
A controlled trial comparing pretransplant total lymphoid irradiation versus posttransplant cyclosporine in type I diabetic cadaveric kidney graft recipients: short-term results. (1987) (4)
Difference in tolerization of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats. (1996) (4)
Intratumoral immunotherapy with anti‐PD‐1 and TLR9 agonist induces systemic antitumor immunity without accelerating rejection of cardiac allografts (2020) (4)
Absence of cross-reactivity between xenoantibodies directed against concordant or discordant xenoantigens in rats. (2000) (3)
Rapid presence of CD4+/CD45RC-regulatory cells in tolerated grafts: Evidence for a protective role in the tolerated tissues (2004) (3)
Phenotypic and functional-analysis of suppressor cells in renal-transplant recipients receiving cyclosporine-a or preoperative total lymphoid irradiation (1985) (3)
Presence of intrinsic B lymphocyte tolerance in mixed but not in complete semiallogeneic bone marrow chimeras. (1997) (3)
Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two (2017) (3)
Immunologic profiles of renal allograft recipients treated with three immunosuppressive regimens, including total lymphoid irradiation, cyclosporine, or azathioprine (1985) (3)
Intestinal allografts delay rejection and prolong survival of combined donor-specific and third party solid organ transplants. (2001) (3)
Factors involved in peripheral T cell tolerance: the extent of clonal deletion or clonal anergy depends on the age of the tolerized lymphocytes. (1992) (3)
Bilateral nephrectomy of the native kidneys reduces the incidence of arterial hypertension and erythrocytosis in kidney graft recipients treated with cyclosporin (1992) (3)
Donor Lymphocyte–Derived Natural Killer Cells Control MHC Class I–Negative Melanoma (2020) (3)
Use of the methylxanthine derivative A802715 in transplantation immunology: II. In vivo experiments. (1997) (3)
Leflunomide-mediated tolerance of B lymphocytes for T-independent xenoantigens needs the presence of these xenoantigens. (1997) (3)
Single center experience with the CTS-HIT allocation system for highly immunized patients. The Leuven Collaborative Group for Transplantation. (1992) (3)
Long-term results after cadaver kidney transplantation have also improved over the last two decades (1991) (3)
Induction of mixed lymphocyte reaction nonresponsiveness after chimeric thymus transplantation (1990) (3)
Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice. (2001) (3)
Evaluation of cyclosporine in a center with high survival rates using conventional immunosuppression (1985) (3)
The effect of FTY 720 on engraftment in a model of spontaneous allograft acceptance (2003) (3)
Mixed bone marrow chimerism across discordant xenogeneic barriers: the solution for inducing xenotransplant tolerance? (2000) (3)
Combined use of FTY720 and cyclosporine A prevents chronic allograft vasculopathy. (2002) (3)
Induction of immunological tolerance by chimeric thymus transplantation. (1989) (3)
Xenograft rejection--all that glitters is not Gal. (2006) (2)
Determination of mixed chimerism by a simple flow cytometry method. (1990) (2)
Induction of xenotransplantation tolerance: a privileged role for the malononitrilamides. (2001) (2)
Calcineurin inhibitor immunosuppression: "Less and later is more" (2007) (2)
Allogeneic thymus transplantation as a means to induce transplantation tolerance. (1990) (2)
Duplex Doppler evaluation of renal allograft dysfunction: Doppler signal quantitation and pathologic correlation. (1990) (2)
Validity and reliability of the Modified Transplant Symptom Occurrence and Symptom Distress Scale (1998) (2)
Mechanisms involved in the differential recovery of CD4 and CD8 T-lymphocytes after local irradiation in mice. (1990) (2)
Is cyclosporine-associated nephrotoxicity progressive? (1987) (2)
Tumor cell kinetics, EGFr expression in oesophageal cancer and cancer of the gastroesophageal junction (1991) (2)
A single center evaluation of the Collaborative Transplant Study (CTS) DNA project (1996) (2)
Translation into the clinic of an experimentally proven pro-regulatory immunomodulatory protocol for intestinal transplantation. Long-term results (2007) (2)
Complications and outcome of combined kidney-pancreas transplantation for end-stage diabetic nephropathy: a retrospective single-center analysis. Leuven Collaborative Group for Transplantation. (1998) (2)
Stable mixed chimerism induced by total lymphoid irradiation or by total body irradiation is maintained by different mechanisms and leads to different graft versus leukemia or graft rejection reactions. (1997) (2)
Addition of a "danger" signal blocks tolerance induction after donor-specific blood transfusion (2006) (2)
Xenograft rejection and the innate immune system (2007) (2)
Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies. (1992) (2)
Pathogenesis of autoimmunity after xenogeneic thymus transplantation (2001) (2)
Are cyclosporine-treated hla-drw6-positive cadaveric kidney allograft recipients high responders (1985) (1)
OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics (2018) (1)
Protective role of asialo GM1+, NK1.1- cells in the occurrence of graft-versus-host disease after total lymphoid irradiation. (1993) (1)
HIGH-DOSE CALCINEURIN INHIBITOR BLOCKS THE GENERATION OF REGULATORY CELLS, WHEREAS LOW-DOSE PROMOTES THEIR DEVELOPMENT. (2004) (1)
Other Forms of Immunosuppression (2014) (1)
Differential effect of immunosuppressive drugs on the development of regulatory cells (2006) (1)
Distinct effects of early and delayed CTLA-4 blockade after murine miHC-disparate allogeneic bone marrow transplantation: graft-versus-host disease versus autoimmunty and graft-versus-leukemia effect (2005) (1)
[Acute renal insufficiency: 1st manifestation of familial sarcoidosis]. (1985) (1)
Other Forms of Immunosuppression (2008) (1)
The study of regulatory T cell (T reg) frequency and function in a CTLA-4-blockade-induced autoimmune syndrome (AIS) in murine allogeneic bone marrow chimeras (2009) (1)
Calcineurin inhibitor: Influence of dose and timing on regulatory cells and graft acceptance (2007) (1)
Delayed CTLA-4-blockade in miHC-mismatched radiation bone marrow chimeras: antileukemic effect is seprated from graft-versus-host but counterbalanced by autoimmunity (2006) (1)
Complement- and xenoantibody-independent discordant xenograft rejection in a guinea pig to rat model. (2000) (1)
The goal of specific immunologic unresponsiveness in clinical kidney transplantation. (1992) (1)
THE EFFECT OF FTY720 (FTY) ON DONOR‐SPECIFIC BLOOD TRANSFUSION (DSBT) INDUCED TOLERANCE; DISCREPANCY BETWEEN HEART TRANSPLANTATION (Htx) AND INTESTINAL TRANSPLANTATION (Itx).: Abstract# 297 Poster Board #‐Session: P144‐I (2000) (1)
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is involved in the pathogenesis of chronic allograft vasculopathy (2001) (1)
Complete freedom from rejection, infection and drug toxicity after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression (2002) (1)
Long-term prognosis of cadaver renal allografts transplanted with cyclosporine as basic immunosuppression. The Leuven Collaborative Group for Transplantation. (1990) (1)
Intestinal transplantation: a single-center experience (2006) (1)
The influence of neonatal thymectomy on the development of radiation myelopathy in rats. (1992) (1)
Single center experience with the CTS-HIT allocation system for highly immunized patients (1992) (1)
Xanthines: ideal immunosuppressants for combination with cyclosporine? (1996) (1)
Long-term survival of hamster-to-rat heart xenografts based on mechanisms of accommodation and tolerance of CD5 B cells. (1997) (1)
Cross-species chemoattraction and xenograft failure: do neutrophils play a role? (2004) (1)
Route of administration determines the efficacy of rapamycin but not the mechanisms of tolerance induced by it in rats. (1996) (1)
Identification of a major Leu 7/OKT 8 positive T-lymphocyte subpopulation in renal transplant patients pre-treated with total lymphoid irradiation. (1986) (1)
CTLA-4-blockade-induced antileukaemic response and autoimmunity after allogeneic bone marrow transplantation: study of regulatory T-cell frequency and function (2009) (1)
The importance of persisting allo-stimulation for the maintenance of tolerance and regulatory T cells (2008) (1)
Long-term prognosis of cadaver renal-allografts transplanted with cyclosporine as basic immunosuppression (1990) (1)
Allogeneic versus syngeneic BMT for prevention of EAE: Role of donor chimerism, donor susceptibility to EAE and alloreactivity (2006) (1)
Opportunities and risks of xenogeneic thymus transplantation. (2003) (1)
Approaches toward T cell-independent and -dependent xenograft tolerance. (2000) (1)
Induction of combined T-cell-dependent and T-cell-independent xenograft tolerance by thymus/heart composite grafts. (2000) (1)
The graft-versus-leukemia effect in allogeneic irradiation bone marrow chimeras: possible suppressive role of irradiation-induced TGF-β (2001) (1)
CTLA-4-blockade-induced autoimmune syndrome in murien allogeneic bone marrow chimeras: study of regulatory T cell frequency and function (2008) (1)
Intestinal Transplantation: from the Laboratory to the Clinics (2008) (1)
Distinct effects of early and delayed CTLA4-blockade after murine miHC-disparate allogeneic bone marrow transplantation: graft-versus-host disease versus auto-immunity (2005) (1)
Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy. (1987) (1)
Immunization with alloantibodies-covered melanoma cells induces regional antitumor effects that become systemic when combined with 5-FU treatment. (2021) (1)
Tolerance in Mlsa mismatched chimeras prepared with allogeneic bone marrow alone or in combination with syngeneic bone marrow. (1999) (1)
Effect of sex hormones on apoptosis in NOD mice: Link to autoimmunity (1998) (1)
A NOVEL MODEL OF ACUTE MYELOID LEUKEMIA SUSCEPTIBLE TO DONOR LYMPHOCYTE INFUSION-INDUCED GRAFT- VERSUS-LEUKEMIA (2006) (0)
Pteridine derivatives for the treatment of diseases associated with TNF-alpha (2004) (0)
Prevention of PNF and prolongation of graft survival in rat islet xenografts in autoimmune NOD mice by a combination of leflunomide and cyclosporine A (1998) (0)
Role of interferon-gamma in the induction of clonal deletion after injection of staphylococcal enterotoxin B. (1993) (0)
“PROPE” TOLERANCE AFTER INTESTINAL TRANSPLANTATION IN MAN. (2004) (0)
Tolerogenic protocol with low immunosuppression for intestinal transplantation: 90% 10-year survival (2013) (0)
Induction of immunologic tolerance after allogeneic thymus transplantation and total lymphoid irradiation. (1989) (0)
Mac1+ suppressor cells develop after alllogeneic bone marrow transplantaiton: possible role inseparating graft-versus-host and graft-versus-leukemia reactivity after delayed donor lymphocyte infusion (2001) (0)
Impaired B-cell tolerance in complete as compared with mixed chimeras after allogeneic bone marrow transplantation. (1993) (0)
Possible role of TGF-beta in the weaker GvL effect of TBI- as compared to TLI-conditioned murien allogeneic BM chimeras: TGF-beta supresses donor BM-derived LAK-cytototxicity (2000) (0)
Homogeneous myocardial expression of human constitutive nitric-oxide synthase by adenoviral gene-transfer during syngeneic heterotopic heart-transplantation (1995) (0)
Influence of splenectomy on the induction of transplantation tolerance after total lymphoid irradiation (TLI) in mice (1986) (0)
Both islet and heart xenografts transplanted in a T-independent xenotolerant host remain susceptible to T cell mediated rejection (2004) (0)
Tolerogenic intestinal transplant protocol prolongs patients and graft surival by promotion of T-regulatory cells (2015) (0)
Intermediate Cell Type Soluble Pneumococcal Polysaccharides via an Ligand Help the IgM Antibody Response to T Lymphocytes Expressing CD 40 + CD 4 (2005) (0)
Effects of vesicoureteral reflux on the transplanted kidney (1998) (0)
Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide. (1996) (0)
The graft-versus-leukemia effect in allogeneic irradiation bone marrow chimeras: possible suppressive role of irradiation-induced TGF-beta. (2001) (0)
PERIPHERAL TOLERANCE THROUGH DONOR‐SPECIFIC BLOOD TRANSFUSION (DSBT) DOES NOT PROTECT AGAINST CHRONIC REJECTION.: Abstract# 907 Poster Board #‐Session: P164‐III (2000) (0)
A new model of endogeneous AML following irradiation and allogeneic bone marrow transplantation (2005) (0)
Combination preparation containing cyclosporin A or FK506, and a xanthine derivative (1994) (0)
Signature Specific for Homing to Regulatory T Cell Profile and Induces a lowCD 127 highCD 25 + Human CD 4 The Vitamin D Analog , TX 527 , Promotes (2010) (0)
CD4+/CD45RC− REGULATORY CELLS ARE RAPIDLY PRESENT IN TOLERATED GRAFTS WHERE THEY DIRECTLY PROTECT ALLOTRANSPLANTED TISSUES FROM CD4+/CD45RC+ EFFECTOR CELLS. (2004) (0)
Results of intestinal transplantation using low-dose immunosuppression (2003) (0)
Differential effect of cyclosporine a and sirolimus on the development of regulatory cells (2005) (0)
A single-center multiple regression analysis of covariates associated with long-term cadaveric renal allograft survival: further improvement of long-term results with CsA. (1995) (0)
Xenotransplantation: a clinically achievable goal? (1997) (0)
Anti-neutrophil cytoplasmic antibody ( ANCA )-associated microscopic polyangiitis following a suppurative wound infection (2006) (0)
Mechanism of Graft-versus-Autoimmunity in Murine EAE: defect inantigen-presenting cells and role of myeloid suppressor cells (2007) (0)
A Regulatory cells inducing regimen allows freedom from rejection after clinical intestinal transplantation under very low immunosuppression (2006) (0)
The liver protects extra-hepatic organs and extra-hepatic organs protect the liver from both acute and chronic rejection (2002) (0)
Role of CD4+ and CD8+ T cells in the rejection of islet or xenoheart grafts in recipients with xenotolerance in the innate immune system (2004) (0)
Graft-versus-leukemia without graft-versus-host disease following delayed leucocyte injection in murien bone marrow chimeras: role of cytokines and regulatory cells (2000) (0)
Defects in the CD4+CD25+ (regulatory) T-cell compartment in mice developing a multiorgan auto-immune syndrome after xenogeneic thymus transplantation (2005) (0)
Optimal cyclosporin levels during the first month after cadaveric kidney transplantation. Leuven Collaborative Group for Transplantation. (1989) (0)
POSSIBLE ROLE OF TGF‐&bgr; IN THE WEAKER GVL‐EFFECT OF TBI‐ AS COMPARED TO TLI‐CONDITIONED MURINE ALLOGENEIC BONE MARROW CHIMERAS: TGF‐&bgr; SUPPRESSES DONOR BONE MARROW‐DERIVED LAKCYTOTOXICITY.: Abstract# 653 (2000) (0)
TRANSFORMING GROWTH FACTOR-&bgr; INHIBITS LYMPHOKINE ACTIVATED KILLER CYTOTOXICITY OF BONE MARROW CELLS: Implications for the Graft-versus-Leukemia Effect in Irradiation Allogeneic Bone Marrow Chimeras1 (2001) (0)
Opposing effects of cyclosporin A and anti-interferon-gamma antibodies on immune tolerance mechanisms. (1997) (0)
Use of methylxanthines (MeXa) as immunosuppressive drugs for organ transplantation. (1997) (0)
A subpopulation of asialo GM1-positive cells plays a protective role in the occurrence of graft-versus-host disease (GVHD) in mice. (1991) (0)
Long-term results after cadaver kidney transplantation have also improved over the last two decades. The Leuven Collaborative Group for Transplantation. (1991) (0)
Induction of transplantation tolerance after allogeneic thymus transplantation: mechanisms involved. (1991) (0)
Allogeneic versus syngeneic bone marrow transplantation for prevention of EAE: role of donor chimerism, donor susceptibility to EAE and alloreactivity (2006) (0)
Xenogeneic islet graft destruction in the human SCID mouse model can only be achieved by human preactivated immune cells (1999) (0)
Paradoxical early upregulation of intragraft Th1 cytokines is associated with graft acceptance following donor‐specific blood transfusion (2003) (0)
Xeno-thymus transplantation in thymectomized rats (2001) (0)
Establishment of operational tolerance to sustain antitumor immunotherapy. (2022) (0)
PRIMARY NONFUNCTION OF ISLET XENOGRAFTS IN SPONTANEOUSLY DIABETIC AUTOIMMUNE NOD MICE: CORRELATION WITH ELEVATED NON-T CELL CYTOKINES AND FASL EXPRESSION IN THE GRAFTS. (1999) (0)
STEROIDS EXPOSURE TRIGGERS ACUTE REJECTION IN AN OTHERWISE ALLOTRANSPLANT TOLERANCE MODEL.: Abstract# 506 Poster Board #‐Session: P146‐II (2000) (0)
Multivisceral transplants including the intestine delay rejection compared with isolated transplants (2002) (0)
Simultaneous inhibition of human CD4 and 4-1BB biogenesis suppresses cytotoxic T lymphocyte proliferation (2021) (0)
Mouse plasma proteomics (2015) (0)
Cell Kinetics and Epidermal Growth Factor Receptor Expression: Useful Guides in Esophageal Cancer? (1993) (0)
The absence of graft-versus-host disease after delayed leucocyte injection early and late after bone marrow transplantation is based on different immunoregulatory mechanisms (2001) (0)
Break of tolerance by high doses of steroids: a differential effect after intestinal and heart transplantation (2002) (0)
Paradoxical early upregulation of intragraft th1 cytokines is associated to graft acceptance (2001) (0)
Early Th1 cytokine upregulation is not necessarily associated with activation-induced cell death in tolerance induction (2002) (0)
Absence of Xeno-rejection and Xenoantibody Production in IL-7 KO Recipients After Xenoheart, but not after Xenoskin Transplantation (2006) (0)
Graft-versus-malignancy effect of donor lymphocyte infusion after bone marrow transplantation in a model of endogenous myelodysplastic syndrome (2006) (0)
INFLUENCE OF ADDITIONAL ADMINISTRATION OF HOST-TYPE BONE MARROW ON THE IMMUNE TOLERANCE OF MIXED ALLOGENEIC CHIMERAS (1998) (0)
CHARACTERISTICS OF B LYMPHOCYTE AND NK CELL TOLERANCE IN A HAMSTER-TO-ATHYMIC NUDE RAT CARDIAC XENOTRANSPLANTATION MODEL (1998) (0)
Primary nonfunction of islet xenografts in spontaneously diabetic autoimmune NOD mice: Correlation with elevated non-T cell cytokines in the grafts (1999) (0)
Allogeneic versus Syngeneic Bone Marrow Transplantation as Treatmen Option in Experimental Autoimmune Encephalitis (2005) (0)
Transcriptional expression of Fas and Fas ligand (FasL) in thymus and spleen of NOD mice (2000) (0)
Possible role of TGF-beta in the weak GvL-effect of murine allogeneic TBI chimeras: TGF-beta suppresses generation of LAK-cytotoxicity from donor BM cells (2000) (0)
INFLUENCE OF TIMING AND DOSE OF CALCINEURIN INHIBITORS EXPOSURE ON GRAFT ACCEPTANCE, TREGS GENERATION AND FOXP3 REGULATION: 1944 (2008) (0)
Maintenance of xenotransplantation tolerance by non-primarly vascularized skin or thymus xenografts (2003) (0)
Functional tolerance by donor-specific blood transfusion (dsbt) in rats is accompanied by microvascular c4d deposition (2011) (0)
Recipient-Type Leucocyte Infusion After Allohsct in Mice Slows Local Growth of Neuroblastoma and Elicits Activation of Intratumoral Cytotoxic NK Cells (2012) (0)
Synergistic immunusuppression by 1,25(OH) 2 D 3 (analogues) and cyclosporin A: animal experiments confirm in vitro data (1994) (0)
Other Forms of Immunosuppression (2019) (0)
Koninklijke Academie voor Geneeskunde van België. EU directive (2004/23/EC) on human tissues and cells: impact on clinical practice and research (2005) (0)
Immunosuppressive effects of pteridinderivativen (2004) (0)
Hamster Heart Xenografts Tolerance in Rats With Long Term Surviving Accommodation and T-Independent B Cell (1997) (0)
Treatment of systemic lupus erythematodes nephritis (1981) (0)
Immunological Monitoring and Renal Transplantation (1984) (0)
Induction, maintenance and breaking of xenotolerance in the non-T cell compartment (2005) (0)
Selective in vivo NK cell manipulations may result in chronic xenograft lesions (2007) (0)
Autoimmunity despite transplantation tolerance after xenogeneic thymus transplantation (2002) (0)
Immunosuppression and Treatment of Rejection in Renal Transplantation (1984) (0)
Characteristics of B lymphocyte and natural killer cell xenotolerance in a concordant hamster-to-athymic rat cardiac xenotransplantation model. (1999) (0)
The effect of FTY 720 on engraftment in a model of spontaneous allograft acceptance (2003) (0)
Regulator cells after allogeneic bone marrow transplantatio: role in graft-versus-host and graft-versus-leukemia reaction after delayed donor lymphocyte infusion (2001) (0)
ISLET AND HEART XENOGRAFTS TRANSPLANTED IN A T-INDEPENDENT XENOTOLERANT HOST REMAIN SUSCEPTIBLE TO CD4+ BUT NOT CD8+ T CELL MEDIATED REJECTION. (2004) (0)
New immunosuppressive agents for organ transplantation. (1997) (0)
Tolerogenic intestinal transplant protocol improves long-term survival by promotion of T-regulatory cells (2015) (0)
Macrophage mediated graft destruction dependent on an intact splenic architercture in T-deficient nude mice (2002) (0)
Letter to the editors (2004) (0)
1,25(OH)2D3 protects against cyclophosphamide-induced diabetes and enhances apoptosis induced by cyclophosphamide (2009) (0)
Immunoregulatory aspects and role of donor NK and T cels after elayed donor leucocyte infusionin minor antigen mismatched BM chimeras (2000) (0)
Long-term survival of hamster heart xenografts in IL-7 knock-out mice (2005) (0)
Expansion of induced regulatory cells after rat cardiac transplantation - Compartments and timing (2003) (0)
Lymphohematopoietic graft-versus-host reactivity and preexsiting chimeric status determines the the graft-versus-leukemia activity of donor lymphocyte infusion after alllogeneic bone marrow transplantation (2002) (0)
Synergistic effect of pretransplant xenogeneic blood transfusion with NK cell and/or B-cell immunosuppression to modulate T-cell-independent xenoreactivity. (2000) (0)
graft-versus-leukemia reactivity of donor lymphocyte infusions possible implications for the graft-versus-host and suppressor activity in spleens of murine radiation marrow chimeras: Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with (2013) (0)
IMMUNOREGULATORY ASPECTS AND ROLE OF DONOR NK AND T CELLS AFTER DELAYED DONOR LEUCOCYTE INFUSION IN MINOR ANTIGEN MISMATCHED BONE MARROW CHIMERAS.: Abstract# 652 (2000) (0)
endothelial cells, platelets and leukocytes GAS6 promotes inflammation by enhancing interactions between (2013) (0)
Potent antitumor activity of the differentiation-inducing agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in choriocarcinoma-bearing rats (1997) (0)
Gas6: an orchestrator of platelet-endothelial-leukocyte cell interactions during hemostasis and inflammation (2006) (0)
TRANSFORMING GROWTH FACTOR-b INHIBITS LYMPHOKINE ACTIVATED KILLER CYTOTOXICITY OF BONE MARROW CELLS (2001) (0)
Factors involved in peripheral T cell tolerance: the extent of clonal deletion or clonal anergy depends on the age of the tolerized lymphocytes (1992) (0)
An intact splenic architecture is essential for rejection of xeno-heart grafts in T deficient nude mice (2001) (0)
IFN-gamma down-regulation in spleen at early after transplantation is related to graft protective effects by donor-specific blood transfusion (DSBT) in rat cardiac transplantation model (2003) (0)
receiving allogeneic bone marrow transplants mice dissociated graft-versus-host and graft-versus-leukemia responses in Crucial role of timing of donor lymphocyte infusion in generating (2007) (0)
Inhibition of primary non-function and prolongation of graft survival of xenogeneic islets by non-steroidal anti-inflammatory agents in non-obese diabetic mice: correlation with diminished non-T-cell cytokines in the grafts and suppression of plasma nitrite production (2002) (0)
Depletion of MDSC improves the anti-neuroblastoma effect of adoptive recipient leukocyte infusion in allogeneic bone marrow transplanted mice (2018) (0)
COMPLEMENT AND KIDNEY DISEASE (2006) (0)
Blood phenotypical pattern in minimally immunosuppressed intestine recipients (2006) (0)
In vitro and in vivo immunomodulatory aspects of murine Multipotent Adult Progenitor Cells (MAPC) (2008) (0)
Induction of Transplantation Tolerance After Total Lymphoid Irradiation : Influence of Thymus Transplantation or Blood Transfusions (1987) (0)
Delayed donor lymphcyte infusion after allogeneic bone marrow transplantation does not provoke graft-versus-host disease but allows for a graft-versus-leukemia effect: immunoregulatory mechanisms and role of Mac1+ suppressor cells (2001) (0)
Radiosensitive marginal zone (MZ) B cells and radioresistant MZ lymphocytes are both essential for infuced, T-independent xenoantibody production (2003) (0)
P3.38: Two decades of intestinal transplantation (ITx) in Leuven. (2019) (0)
Induction of xenotransplant tolerance. (2000) (0)
The hu-PBL-SCID mouse as model for islet xenotransplantation (1999) (0)
Meningitis due to Listeria Meningitis (1988) (0)
Cooperativity of a 1,25-dihydroxyvitamin D-3 non-steroidal E-ring analog with classical immunosuppressants (1999) (0)
Current problems of clinical immunosuppression in renal-transplantation (1982) (0)
RECIPIENT T CELLS GENERATED BY A XENOTHYMUS ARE TOLERANT TO VASCULARIZED GRAFTS FROM THE THYMUS DONOR BUT DEVELOP AUTOIMMUNITY TO MULTIPLE SELF‐ORGANS.: Abstract# 1043 (2000) (0)
34PImmunotherapy for high-risk neuroblastoma: allogeneic stem cell transplantation and recipient leucocyte infusion (2015) (0)
B lymphocyte subpopulations involved in rapidly-induced, T-cell independent xenoantibody formation (2007) (0)
Experimental transplantation in rats for the study of the pathogenesis and treatment of chronic rejection (1997) (0)
Diabetic BB/PFD rats reject MHC incompatible islet grafts, but do not destroy MHC compatible islet grafts. (1994) (0)

This paper list is powered by the following services:

Other Resources About Mark Waer

en.wikipedia.org

What Schools Are Affiliated With Mark Waer?

Mark Waer is affiliated with the following schools:

KU Leuven